SANUWAVE Health (SNWV) EBIT Margin (2010 - 2026)

SANUWAVE Health (SNWV) has reported EBIT Margin for 17 consecutive years, with 2.88% the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBIT Margin fell 1718.0% year-over-year to 2.88% in Q2 2026; TTM through Jun 2026 was 3.41%, a 1075.0% decrease from a year earlier, with the FY2025 full-year figure at 11.23%, down 57.0% from the prior year.
• EBIT Margin was 2.88% for Q2 2026 at SANUWAVE Health, up from 11.69% in the prior quarter.
• Over five years, EBIT Margin peaked at 23.0% in Q2 2024 and troughed at 78.52% in Q2 2022.
• A 5-year average of 10.51% and a median of 1.78% in 2025 frame the typical range for EBIT Margin.
• Across the five-year window, EBIT Margin surged 14644 bps in 2022 and tumbled 1812 bps in 2026, its largest moves.
• Over 5 years, EBIT Margin stood at 26.6% in 2022, then soared by 156 bps to 14.86% in 2023, then surged by 31 bps to 19.48% in 2024, then slipped by 23 bps to 14.95% in 2025, then tumbled by 119 bps to 2.88% in 2026.
• The last three EBIT Margin figures came in at 2.88% (Q2 2026), 11.69% (Q1 2026), and 14.95% (Q4 2025), per Business Quant data.